Four lanes on one page
The telehealth page carries a four-lane table: a compounded injection and a needle-free route for each of the two compounds, each with its own figure and its own description. Seven of the seventy-three sellers here publish a needle-free compounded price at all, and fewer still price one beside the injectable version of the same drug.
The oral tirzepatide lane is the scarcer of the two. It is also priced above its injectable counterpart, which is the reverse of the usual arrangement in this comparison and worth noticing before assuming the oral route is the cheaper one.
Every lane states that the medication is included, if prescribed. That is the difference between a programme fee and a treatment price, and it is stated on the page rather than left to intake.
The entry figure means two things
On the telehealth page the entry figure is a starting monthly rate. On the medication page the same number is qualified as a rate per month for a twelve-month plan paid in full — which is a single prepayment divided by twelve, not a monthly bill.
Both pages were live on the same day. Both statements are recorded verbatim on this row and neither is resolved, because resolving them would mean picking a side of a conflict the seller has not.
This is why the comparison table on this site prints no monthly suffix beside that particular figure. Omitting the suffix asserts nothing; printing it would assert one of the two terms as the true one. The other three lanes appear on one surface only, with one term each, and are recorded as monthly.
Every lane is also a starting-at figure, and no ladder above any of them is published. So the entry number answers what the cheapest month might be at the lowest dose, and nothing about what a maintained dose costs.
A prescriber named, a pharmacy not
Forty of the seventy-three sellers here name an individual prescribing clinician, and this is one of them: a chief medical officer with credentials, named as a person rather than as a category.
Fifty-three of the seventy-three name no compounding pharmacy at all, and this is one of those. Compounded preparations are sold here and the site carries the standard disclaimer sitewide, but which pharmacy prepares them is never said.
The terms name an affiliate that charges the card. That affiliate also appears on another seller in this comparison, which is a fact about the plumbing behind two brands rather than about either one's care, and it is the kind of thing a reader comparing several tabs at once cannot see from the front pages.
Two footprints, neither of them this one
The locations page publishes a state-by-state clinic count, and four of the nine states named have no clinics at all. A list of states is not a footprint just because it is a list of states, and a count of zero is an answer that reads like a listing.
The telehealth page — where these prices live — publishes no list at all. What it publishes is a condition: that a buyer lives in a state where the telehealth service is currently available. Which states those are is never said.
This row records an empty service area for that reason, with both statements quoted, and does not merge a clinic directory into a telehealth footprint. Forty-one of the seventy-three sellers here publish no service area, so the silence is ordinary; publishing two different kinds of answer is less so.
No governing law, and no dispute section at all
A census of the full terms found no choice-of-law clause, no forum, no venue, no arbitration clause and no state name. It also found that the terms never name the operating company, referring to the business throughout as this practice. The company's name appears in the privacy policy instead.
Several sellers on this roster publish no governing-law state, so this is a normal condition of the market rather than an anomaly. What is less usual is the absence of a dispute-resolution section of any kind, which is the part of a terms document that says what happens when something goes wrong.
Twenty of the seventy-three sellers here say nothing either way about a membership or programme fee, and this is one of them. A word-bounded census across six pages found no membership sentence in either direction.
The site also carries third-party certifications and press accolades as trust signals. Those are the seller's own claims, repeated here as claims, and this comparison did not verify either.
Options Medical Weight Loss's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $199⚠ Two terms, on two of the seller's own live pages, on the same day. The four-lane table says "Starting at $199/mo. · Semaglutide Injections · Achieve Your Weight Loss Goals with Compounded Semaglutide Injections · Medication Included". The medication page says $199 "(per month for a 12-month plan paid in full)" — a twelve-month prepayment divided by twelve. Both are quoted here and neither is resolved; the page-level line is "Telehealth medical weight loss programs starting at $199/month · GLP-1 medication included in all programs, if prescribed · No insurance required; HSA/FSA eligible." | September 2026source |
| Tirzepatide (compounded) | $299/moFrom the seller's four-lane table: "Starting at $299/mo. · Compounded Tirzepatide for Weight Loss, Personalized for You · Medication Included". A starting figure, in the seller's own word, and the page states no ladder above it. ⚠ The site's medication page reprices its entry lane as a twelve-month prepayment; that qualification is attached to the semaglutide figure there, not to this one. | September 2026source |
| Tirzepatide (compounded-oral) | $339/moFrom the same four-lane table: "Starting at $339/mo. · Advanced oral dual-action therapy". An oral tirzepatide price is uncommon in this comparison, and the lane sits beside the injectable one at a higher figure. Medication is included in all programmes, if prescribed. | September 2026source |
| Semaglutide (compounded-oral) | $239/moFrom the same four-lane table: "Starting at $239/mo. · Oral GLP-1 therapy". The oral lane is priced above the injectable lane for the same compound, which is the reverse of the usual arrangement in this comparison. | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 73 providers reviewed here are paid partners today; the other 69 are not. See how this works.
See Options Medical Weight Loss's current price →Good fit if
- Readers who want an oral and an injectable lane priced side by side for both compounds, on one page, before any intake.
- Anyone specifically looking for an oral tirzepatide figure, which very little of this comparison publishes.
- Buyers who want the medication stated as included rather than discovering a separate drug bill later.
- People who want the chief medical officer named as an individual with credentials.
Look elsewhere if
- Anyone who needs to know what the entry figure actually commits them to. Two of this seller's own pages give it two different terms.
- Readers who want an FDA-approved product. Everything here is compounded.
- Buyers who need their state confirmed for the telehealth line, which publishes no list.
- People who want a governing-law clause, a forum, or an operating company named in the terms they are agreeing to.
- Anyone who needs the compounding pharmacy named.
How this review was verified
- Read the telehealth page and the medication page in a browser and audited every dollar element for computed opacity, visibility and a real laid-out rectangle before recording a figure.
- Recorded both of the seller's own statements about the entry figure verbatim, and set that row's period so no template prints a monthly suffix beside a figure whose term the seller has stated two ways.
- Kept the other three lanes as monthly, because each appears on one surface with one term, and said so in the row rather than applying one lane's ambiguity to the rest.
- Censused the full terms for a governing-law clause, a forum, a venue, an arbitration clause, a state name and the operating company's own name, and found none of them; the company is named in the privacy policy instead.
- Word-bounded the membership census across six rendered pages before recording an absence rather than a denial.
- Recorded the clinic footprint and the telehealth condition separately, including the four named states with no clinics, rather than merging a directory of clinics into a service area.
- Attributed the third-party certification and the press accolade to the seller and verified neither.
- Searched the agency's published warning-letter record for the trading name and the operating company, 2017 to 2026, and read every returned row: none of them names this company. That search covers warning letters only; untitled letters are published separately and were not searched.
- Probed the host with a nonsense path at two depths in the same run as the reading; both returned a genuine not-found page with a distinct body.